Daily non-political popular news in brief.
Common cancer treatments toxic to healthy brain cells
11-29-2006 · EurekAlert!Common drugs used to treat cancer may be more harmful to healthy brain cells than the cancer cells that they are intended to destroy, according to a new study. The results, which also indicate that chemotherapy may cause long-term brain damage, represent the closest that scientists have come to pinpointing the underlying physiological cause of "chemo brain," a common side effect of cancer treatment that scientists are only now beginning to comprehend.
Read more »
Keywords: cancer, treatments, toxic, healthy, brain, cells, treatment, cell
« Previous | Next »
Similar news on "Common cancer treatments toxic to healthy brain cells":
- New strategies with greater antitumorous efficacy
10-02-2007 · EurekAlert!
One of the biggest problems in the current treatment of cancer is that the agents that are efficacious in the destruction of tumorous cells are, at the same time, extremely toxic for the rest of the healthy cells and tissues of the patient. To address the problem the University of the Basque Country is seeking more specific treatments and studying the differences between tumorous cells and healthy ones.
Similar news · Read more »
- Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
01-30-2008 · EurekAlert!
In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
Similar news · Read more »
- Antidepressants stimulate new nerve cells in adult monkeys, may have implications for humans
05-04-2007 · EurekAlert!
In adult monkeys, an antidepressant treatment has induced new nerve cell growth in the hippocampus, a brain area responsible for learning and memory. A similar process may occur in humans, the research suggests, and may help explain the effectiveness of antidepressant treatments.
Similar news · Read more »
- Chemotherapy can be more toxic to brain cells than to cancer cells and may cause brain damage
11-29-2006 · EurekAlert!
Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target. A study published today in the open access journal Journal of Biology shows that clinical doses of chemotherapeutic drugs used to treat many common cancers cause long-term damage to the brains of mice.
Similar news · Read more »
- Research suggests new treatment suitable for all patients
01-01-2008 · EurekAlert!
New research at Wake Forest University Baptist Medical Center suggests that a three-drug cocktail may one day improve outcomes in patients with glioblastoma multiforme, a type of brain tumor with a dismal prognosis. Two of the drug candidates have been developed, and the team is working on the third -- all targeted to kill or impair cancer cells and spare healthy brain.
Similar news · Read more »
- Researchers identify genes that allow brain cancer-causing stem cells to resist treatment
12-14-2006 · EurekAlert!
Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute, who first isolated cancer stem cells in adult brain tumors in 2004, have now found these cells to be highly resistant to chemotherapy and other treatments. Even if a tumor is almost completely obliterated, it will regenerate from the surviving cancer stem cells and be even more resistant to treatment than before.
Similar news · Read more »
- New algorithm matches any tumor cells to best possible anti-cancer treatments
07-23-2007 · EurekAlert!
An algorithm that could help rapidly sort molecular information about a cancer patient's particular tumor and could help match this information to the right drug treatment would be a breakthrough of enormous value. Two University of Virginia researchers have pioneered just such a system. Using a panel of 60 diverse, human cancer cell lines from the National Cancer Institute (NCI-60), the researchers devised and tested an algorithm designed to match the best potential treatment(s) for a particular tumor in a particular patient.
Similar news · Read more »
- Scientists identify switch for brain's natural anti-oxidant defense
10-19-2006 · EurekAlert!
Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic "free radicals," a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer and aging.
Similar news · Read more »
- Tumor-reactive T cells boosted by hematopoietic stem cell transplantation
02-01-2007 · EurekAlert!
Treatment for skin cancer by infusion of tumor-reactive T cells requires patients to be pre-treated with agents that transiently decrease the number of immune cells (nonmyeloablative agents). A study in mice now indicates that pre-treatment with more intense immune cell-depleting strategies (known as myeloablative strategies) and a hematopoietic stem cell transplant enables infused tumor-reactive CD8+ T cells to increase in number more than pre-treatment with nonmyeloablative agents, and this correlates with increased tumor regression.
Similar news · Read more »
- Therapeutic peptide frees the protein p73 to kill tumor cells
03-08-2007 · EurekAlert!
p53 suppresses tumor development by inducing tumor cell death. However, targeting p53 for the treatment of cancer is confounded by the fact that genetic mutations cause loss or inactivation of p53 in approximately 50 percent of human cancers. Now, a new study indicates that targeting the p53-related protein p73 in mice induces the regression of established tumors of human origin, leading to the suggestion that p73 might be a viable target for developing anticancer therapeutics.
Similar news · Read more »
